185 related articles for article (PubMed ID: 25264935)
1. Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonist in female rats.
He M; Zhang Q; Deng C; Wang H; Huang XF
Endocrinology; 2014 Dec; 155(12):4895-904. PubMed ID: 25264935
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.
He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF
Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512
[TBL] [Abstract][Full Text] [Related]
3. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Deng C; Lian J; Pai N; Huang XF
J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
[TBL] [Abstract][Full Text] [Related]
4. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
Lian J; Huang XF; Pai N; Deng C
Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
Han M; Deng C; Burne TH; Newell KA; Huang XF
Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
[TBL] [Abstract][Full Text] [Related]
7. The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.
He M; Deng C; Huang XF
CNS Drugs; 2013 Jun; 27(6):423-34. PubMed ID: 23640535
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk of hypothalamic chemerin, histamine, and AMPK in diet-and olanzapine-induced obesity in rats.
Samy DM; Mostafa DK; Abdelmonsif DA; Ismail CA; Hassaan PS
Life Sci; 2021 Nov; 284():119897. PubMed ID: 34450172
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
Lian J; Huang XF; Pai N; Deng C
Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
[TBL] [Abstract][Full Text] [Related]
10. Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways.
Liu X; Lian J; Hu CH; Deng C
Pharmacol Res; 2015 Oct; 100():36-46. PubMed ID: 26218603
[TBL] [Abstract][Full Text] [Related]
11. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
[TBL] [Abstract][Full Text] [Related]
12. Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
Barak N; Beck Y; Albeck JH
J Psychopharmacol; 2016 Mar; 30(3):237-41. PubMed ID: 26839321
[TBL] [Abstract][Full Text] [Related]
13. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
Weston-Green K; Huang XF; Han M; Deng C
Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
[TBL] [Abstract][Full Text] [Related]
14. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
Weston-Green K; Huang XF; Lian J; Deng C
Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine increases AMPK-NPY orexigenic signaling by disrupting H1R-GHSR1a interaction in the hypothalamic neurons of mice.
Chen X; Yu Y; Zheng P; Jin T; He M; Zheng M; Song X; Jones A; Huang XF
Psychoneuroendocrinology; 2020 Apr; 114():104594. PubMed ID: 32007669
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
[TBL] [Abstract][Full Text] [Related]
17. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?
Deng C; Weston-Green K; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats.
Deng C; Weston-Green KL; Han M; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):915-20. PubMed ID: 17368684
[TBL] [Abstract][Full Text] [Related]
19. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.
Poyurovsky M; Pashinian A; Levi A; Weizman R; Weizman A
Int Clin Psychopharmacol; 2005 Mar; 20(2):101-3. PubMed ID: 15729086
[TBL] [Abstract][Full Text] [Related]
20. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
